Matrine Glucose Injection
Function and Efficacy
Intraperitoneal injection of matrine into mice with cholestatic jaundice induced by 1-naphthyl isothiocyanate can reduce the levels of serum alanine aminotransferase, aspartate aminotransferase and serum conjugated bilirubin, and alleviate liver cell damage in model animals.
Ingredients
Matrine
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| MatrineIngredients |
Intraperitoneal injection of the drug into mice with cholestatic jaundice induced by 1-naphthyl isothiocyanate can reduce the levels of serum alanine aminotransferase, aspartate aminotransferase and serum conjugated bilirubin, and alleviate liver cell damage in the model animals. More |
519-02-8 | 8 |
Appearance
This product is a colorless or almost colorless clear liquid.
Indication
Used for elevated transaminase and abnormal bilirubin in chronic hepatitis B.
Usage and Dosage
Slow intravenous drip, once a day, 250 ml each time, 2 months as a course of treatment.
Adverse Reactions
This product will not cause adverse reactions if used according to the above usage and dosage. However, if the drip speed is too fast, it will cause adverse reactions such as dizziness and nausea.
Precautions
It is contraindicated for those who are allergic to this product.
Drug Interactions
Not yet clear.
Storage
Keep in dark, airtight, cool and dark place.
Packaging Specification
250ml: matrine 0.15g and glucose 12.5g
Manufacturer
Cisen Pharmaceutical Co., Ltd.
-
Founded in:
1998-11-06 -
Address:
Tongji Science and Technology Industrial Park, Jining High-tech Zone -
Tax NO.:
91370800706117999P -
Registered Funds:
452,754,129 yuan -
Website:
-
Email: